Case Report

Split Viewer

Korean J Hematol 2011; 46(2):

Published online June 21, 2011

https://doi.org/10.5045/kjh.2011.46.2.139

© The Korean Society of Hematology

Successful treatment with erythromycin for idiopathic thrombocytopenic purpura

Masashi Ohe1*, and Satoshi Hashino2

1Department of General Medicine, Hokkaido Social Insurance Hospital, Sapporo, Japan.

2Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Correspondence to : Correspondence to Masashi Ohe, M.D., Ph.D. Department of General Medicine, Hokkaido Social Insurance Hospital, 1-8-3-18 Nakanoshima, Toyohira-ku, Sapporo 062-8618, Japan. Tel: +81-11-831-5151, Fax: +81-11-821-3851, masshi@isis.ocn.ne.jp

Received: May 22, 2011; Revised: June 14, 2011; Accepted: June 14, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection status. Case 1, an 88-year-old woman who was an H. pylori-positive ITP patient, was treated with clarithromycin (CAM). CAM was effective temporarily. As an alternative to CAM, she was successfully treated with erythromycin (EM) for more than 7 months. Case 2, a 61-year-old man who was an H. pylori-negative ITP patient, was unsuccessfully treated with CAM but successfully treated with EM. Case 3, a 75-year-old woman who was a H. pylori-negative ITP patient, was treated with CAM. CAM was effective temporarily. After approximately 6 months, she was treated with EM for a common cold, and her platelet count increased rapidly. Based on these findings, macrolide treatment was effective for ITP. The effectiveness of macrolides might suggest immunomodulatory effects as well as antibacterial effects for H. pylori.

Keywords Idiopathic thrombocytopenic purpura, Erythromycin, Macrolide

Article

Case Report

Korean J Hematol 2011; 46(2): 139-142

Published online June 21, 2011 https://doi.org/10.5045/kjh.2011.46.2.139

Copyright © The Korean Society of Hematology.

Successful treatment with erythromycin for idiopathic thrombocytopenic purpura

Masashi Ohe1*, and Satoshi Hashino2

1Department of General Medicine, Hokkaido Social Insurance Hospital, Sapporo, Japan.

2Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Correspondence to: Correspondence to Masashi Ohe, M.D., Ph.D. Department of General Medicine, Hokkaido Social Insurance Hospital, 1-8-3-18 Nakanoshima, Toyohira-ku, Sapporo 062-8618, Japan. Tel: +81-11-831-5151, Fax: +81-11-821-3851, masshi@isis.ocn.ne.jp

Received: May 22, 2011; Revised: June 14, 2011; Accepted: June 14, 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection status. Case 1, an 88-year-old woman who was an H. pylori-positive ITP patient, was treated with clarithromycin (CAM). CAM was effective temporarily. As an alternative to CAM, she was successfully treated with erythromycin (EM) for more than 7 months. Case 2, a 61-year-old man who was an H. pylori-negative ITP patient, was unsuccessfully treated with CAM but successfully treated with EM. Case 3, a 75-year-old woman who was a H. pylori-negative ITP patient, was treated with CAM. CAM was effective temporarily. After approximately 6 months, she was treated with EM for a common cold, and her platelet count increased rapidly. Based on these findings, macrolide treatment was effective for ITP. The effectiveness of macrolides might suggest immunomodulatory effects as well as antibacterial effects for H. pylori.

Keywords: Idiopathic thrombocytopenic purpura, Erythromycin, Macrolide

Fig 1.

Figure 1.

Change of platelet counts following clarithromycin (CAM) and erythromycin (EM) treatments.

Blood Research 2011; 46: 139-142https://doi.org/10.5045/kjh.2011.46.2.139

Fig 2.

Figure 2.

Change of platelet counts following prednisolone (PSL), methylprednisolone (mPSL), CAM, and EM treatments.

Blood Research 2011; 46: 139-142https://doi.org/10.5045/kjh.2011.46.2.139

Fig 3.

Figure 3.

Change of platelet counts following CAM and EM treatments.

Blood Research 2011; 46: 139-142https://doi.org/10.5045/kjh.2011.46.2.139
Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download